|Other Names||Serine/arginine-rich splicing factor 8, Pre-mRNA-splicing factor SRP46, Splicing factor SRp46, Splicing factor, arginine/serine-rich 2B, SRSF8, SFRS2B, SRP46|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13474a was selected from the N-term region of SFRS2B. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Involved in pre-mRNA alternative splicing.|
|Tissue Location||Strongly expressed in pancreas, spleen and prostate. Weakly expressed in lung, liver and thymus|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The SR (serine/arginine-rich) family contains a number ofphosphoproteins that function as essential and alternative splicingfactors. The SR family of proteins is characterized by the presenceof a ribonucleoprotein (RNP)-type RNA binding motif and acarboxyl-terminal arginine-serine-rich (RS) domain. The proteinencoded by this gene is a member of the SR family and functions asan essential splicing factor in vitro. This gene is thought to bean expressed PR264/SC35 retropseudogene.
Manley, J.L., et al. Genes Dev. 24(11):1073-1074(2010)Lareau, L.F., et al. Nature 446(7138):926-929(2007)Olsen, J.V., et al. Cell 127(3):635-648(2006)Li, J., et al. Mol. Cell. Biol. 23(21):7437-7447(2003)Grottke, C., et al. Int. J. Cancer 88(4):535-546(2000)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.